Related references
Note: Only part of the references are listed.Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin
Nilgun Yildirim et al.
SUPPORTIVE CARE IN CANCER (2020)
Central Obesity is Associated With Neuropathy in the Severely Obese
Brian C. Callaghan et al.
MAYO CLINIC PROCEEDINGS (2020)
Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy
Takashi Saito et al.
ONCOLOGY RESEARCH (2019)
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
Alex Molassiotis et al.
BMC CANCER (2019)
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
Alex Molassiotis et al.
BRAIN AND BEHAVIOR (2019)
Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101
Myra Barginear et al.
ONCOLOGIST (2019)
Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes
Tejaswi Kandula et al.
JAMA NEUROLOGY (2018)
The relationship between chemotherapy-induced neuropathy and quality of life in breast cancer survivors.
Barbara Sharon Gordon et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Zohreh Ghoreishi et al.
BMC CANCER (2018)
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer
Kathleen A. Griffith et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2017)
Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics
Andreas A. Argyriou et al.
NATURE REVIEWS NEUROLOGY (2017)
Biomarker analysis using circulating tumor DNA in patients treated with sorafenib for advanced hepatocellular carcinoma
S. R. Park et al.
ANNALS OF ONCOLOGY (2017)
Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer
Michael J. Raphael et al.
CLINICAL COLORECTAL CANCER (2017)
Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial
S. B. Park et al.
ANNALS OF ONCOLOGY (2017)
Anemia: an independent risk factor of diabetic peripheral neuropathy in type 2 diabetic patients
Fan Wu et al.
ACTA DIABETOLOGICA (2017)
Erythropoietin for cancer-associated malignant anemia: A meta-analysis
Feng Zhao et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Prevalence of Oxaliplatin-induced Chronic Neuropathy and Influencing Factors in Patients with Colorectal Cancer in Iran
Ali Shahriari-Ahmadi et al.
Asian Pacific Journal of Cancer Prevention (2016)
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
Ting Bao et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy
Roser Velasco et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2016)
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
Alessandro Ottaiano et al.
ONCOLOGY (2016)
Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment
Noah R. Zanville et al.
SUPPORTIVE CARE IN CANCER (2016)
Diagnosis of iron-deficient states
Natasha M. Archer et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2015)
A review of relative dose intensity and survival in patients with metastatic solid tumors
Laura J. Havrilesky et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study
Wenjie Zhu et al.
PLOS ONE (2015)
Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome
Ling Han et al.
DIABETOLOGY & METABOLIC SYNDROME (2015)
Serum albumin is associated with peripheral nerve function in patients with type 2 diabetes
Lu Li et al.
ENDOCRINE (2015)
Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry
Nicole P. M. Ezendam et al.
GYNECOLOGIC ONCOLOGY (2014)
Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
Floortje Mols et al.
SUPPORTIVE CARE IN CANCER (2014)
Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin
Linh M. Alejandro et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis
Susanna B. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV
Bruno Vincenzi et al.
SUPPORTIVE CARE IN CANCER (2013)
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial
Beatrice Weber et al.
SUPPORTIVE CARE IN CANCER (2013)
Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
Rebecca M. Speck et al.
JOURNAL OF ONCOLOGY PRACTICE (2013)
Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median
Christophe Leys et al.
JOURNAL OF EXPERIMENTAL SOCIAL PSYCHOLOGY (2013)
Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma
Hans Wildiers et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
Susanna B. Park et al.
ONCOLOGIST (2011)
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
Susanna B. Park et al.
BRAIN (2009)
Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies
S. I. van Nes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Reversal of iron deficiency anemia-induced peripheral neuropathy by iron treatment in children with iron deficiency anemia
N Kabakus et al.
JOURNAL OF TROPICAL PEDIATRICS (2002)
Influences of handedness and gender on the Grooved Pegboard Test
SL Schmidt et al.
BRAIN AND COGNITION (2000)
Share Paper
